Evidence-based·Last reviewed May 31, 2026·How we grade evidence

Arabinogalactan

Prebiotic

A soluble dietary fiber extracted from western larch (Larix occidentalis) wood, GRAS by the FDA since 2003 at up to 30 g/day. Acts as a prebiotic — fermented in the colon by Bifidobacterium and Lactobacillus, producing short-chain fatty acids. A handful of small RCTs report modest improvements in vaccine antibody response, cold-incidence reduction, and gut microbiota markers. Generally well tolerated.

Quick decision guide

May help most

Adults seeking a tolerable soluble-fiber prebiotic, especially during cold/flu season or to support gut microbiota diversity.

Common dosing range

1.5–4.5 g/day (RCTs); up to 30 g/day GRAS limit. Most immune-function trials used 4.5 g/day.

When to expect effects

Days–weeks for microbiota shifts; 8–12 weeks for vaccine antibody / cold-incidence endpoints.

Watch out for

Like all fermentable fibers, can cause gas and bloating at higher doses. People with severe IBS or low-FODMAP requirements should test tolerance carefully.

Evidence snapshot

Prebiotic / gut microbiota supportModerate
Cold incidence reductionEmerging
Vaccine antibody responseEmerging
GI tolerance vs other prebiotic fibersGenerally good

What is it

Arabinogalactan is a branched polysaccharide of arabinose and galactose. The most common supplement source is the heartwood of larch trees (Larix occidentalis). It is sold as a prebiotic fiber with immune-modulating claims.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You want a well-tolerated soluble fiber that doubles as a prebiotic
You're trying to support gut microbiota diversity alongside or in place of inulin / FOS (often better tolerated than inulin for gas)
You want a low-risk supplement to try during cold/flu season — modest effect in the trials, but real
You're getting a pneumococcal, flu, or other adult vaccine and want a low-cost adjunct that might modestly improve antibody response

Probably skip if…

You're hoping for strong evidence — the human RCT base is small and trials are mostly single-centre
You have IBS with significant gas / bloating burden — start at 1 g/day and titrate; or pick a less-fermentable fiber
You're looking for a substitute for vaccination, antibiotics, or evidence-based illness management
You're hoping for a clinically meaningful weight-loss or LDL-lowering effect — arabinogalactan is not the strongest fiber for either

Evidence at a glance

Prebiotic / gut microbiota support

Good Evidence
Effect
Significant increase in Bifidobacterium and Lactobacillus stool counts after 4 weeks at 4.5 g/day
Best fit
Adults wanting to shift gut microbiota toward beneficial fermenters; people who tolerate fermentable fiber
Time
Weeks

Common cold incidence reduction

Limited Evidence
Effect
~23% reduction in cold incidence at 4.5 g/day over 12 weeks; modest effect needs replication
Best fit
Adults during cold/flu season willing to take 4.5 g/day for 12 weeks
Time
8–12 weeks

Vaccine antibody response (pneumococcal)

Limited Evidence
Effect
Significant increase in pneumococcal vaccine antibody response in a single small RCT
Best fit
Adults receiving pneumococcal vaccination who could start arabinogalactan 4–8 weeks before
Time
4–8 weeks before vaccination

General immune function in healthy adults

Limited Evidence
Effect
Modest changes in mucosal IgA, NK cell markers; clinical-endpoint translation is the Riede and Udani trials above
Best fit
Adults wanting a low-risk immune-support adjunct alongside sleep, exercise, and vaccination
Time
Weeks for biomarker change

Evidence for 4 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Prebiotic / gut microbiota support

Biomarker support
Good Evidence

Larch arabinogalactan is fermented in the colon by Bifidobacterium and Lactobacillus species, producing short-chain fatty acids (butyrate, propionate, acetate) that support colonocyte health and gut barrier function. The Dion 2016 randomized crossover trial in 30 healthy adults found 4.5 g/day for 4 weeks significantly increased Bifidobacterium and Lactobacillus stool counts. Effect is consistent across small human trials and is the strongest documented benefit.

Effect size
Significant increase in Bifidobacterium and Lactobacillus stool counts after 4 weeks at 4.5 g/day
Time to effect
Weeks
Best fit
Adults wanting to shift gut microbiota toward beneficial fermenters; people who tolerate fermentable fiber
Less likely
People with severe IBS or low-FODMAP requirements without titration

Bottom line: Reliable prebiotic effect at 4.5 g/day. Well-tolerated alternative to inulin or FOS for many people.

SourceDion et al., 2016 — Journal of Nutritional ScienceKelly, 1999 — Alternative Medicine ReviewNIH ODS — Dietary Fiber overview — Office of Dietary Supplements

Common cold incidence reduction

Supplement benefit
Limited Evidence

A 199-adult RCT (Riede 2013) reported a 23% reduction in cold-episode incidence over 12 weeks at 4.5 g/day vs placebo during cold/flu season (p=0.05 borderline significance). Cold-related days of illness were also reduced. Single-centre, mid-sized trial; effect is modest and needs replication. Mechanism likely involves enhanced mucosal IgA, NK cell activity, and prebiotic effects on gut-immune axis.

Effect size
~23% reduction in cold incidence at 4.5 g/day over 12 weeks; modest effect needs replication
Time to effect
8–12 weeks
Best fit
Adults during cold/flu season willing to take 4.5 g/day for 12 weeks
Less likely
Anyone expecting dramatic protection or substitute for vaccination

Bottom line: Modest cold-incidence reduction in a single RCT — promising but not proven.

SourceRiede et al., 2013 — Current Medical Research and Opinion

Vaccine antibody response (pneumococcal)

Supplement benefit
Limited Evidence

A 75-adult RCT (Udani 2010) found 4.5 g/day larch arabinogalactan for 8 weeks significantly increased antibody response to the 23-valent pneumococcal vaccine vs placebo. Single small trial; cold-incidence endpoint trended lower but did not reach significance. The vaccine-response effect is intriguing but needs replication in larger and varied vaccine settings.

Effect size
Significant increase in pneumococcal vaccine antibody response in a single small RCT
Time to effect
4–8 weeks before vaccination
Best fit
Adults receiving pneumococcal vaccination who could start arabinogalactan 4–8 weeks before
Less likely
Anyone expecting confirmed benefit for other vaccines (flu, COVID, hepatitis); single trial doesn't generalize

Bottom line: Single-trial signal of improved vaccine response. Low risk to try; not yet a confirmed clinical recommendation.

SourceUdani et al., 2010 — Nutrition Journal

General immune function in healthy adults

Mechanism only
Limited Evidence

Beyond the specific vaccine-response and cold-incidence trials above, mechanistic studies and one or two pilot trials suggest larch arabinogalactan increases NK cell activity, mucosal IgA, and macrophage activation. These are biomarker / mechanism endpoints, not hard clinical outcomes. Effects are plausible given the prebiotic action on gut-immune axis.

Effect size
Modest changes in mucosal IgA, NK cell markers; clinical-endpoint translation is the Riede and Udani trials above
Time to effect
Weeks for biomarker change
Best fit
Adults wanting a low-risk immune-support adjunct alongside sleep, exercise, and vaccination
Less likely
Anyone expecting hard clinical-outcome benefit

Bottom line: Mechanism-only support for general immune function; clinical translation rests on the small trials cited above.

SourceKelly, 1999 — Alternative Medicine Review

How it works

Larch arabinogalactan is fermented by colonic bacteria (especially Bifidobacteria and Lactobacilli) to short-chain fatty acids, lowering colon pH and feeding beneficial flora. Some studies suggest enhanced NK cell activity and modest improvement in immune response to vaccines, though clinical effects are modest. It also acts as a soluble fiber, drawing water and supporting bowel regularity.

How to take it

1. Typical dose
• Prebiotic / microbiota support: 1.5–4.5 g/day (one or two daily servings) • Immune support trial dose: 4.5 g/day • Upper GRAS limit: 30 g/day, far above the studied effective dose
2. Higher studied dose
Up to 9–15 g/day in older Kelly-era reviews. Higher doses don't reliably add benefit and increase gas / bloating.
3. Timing
Time of day matters little for chronic prebiotic effects. Spread larger doses across meals to reduce GI symptoms.
4. With food
With or without food; usually mixed into water, smoothies, or coffee. Tasteless and dissolves easily.
5. Split dosing
Split into 2 doses if going above 4.5 g/day or if gas/bloating appears at single dose.
6. How long to try
Microbiota shifts in 2–4 weeks; cold-incidence and vaccine-response trials ran 8–12 weeks. Long-term use is well-tolerated within the GRAS limit.

What to track

GI tolerance — gas, bloating, stool form changes in the first 1–2 weeks
Cold incidence and severity if using during cold/flu season
Vaccine timing — start 4–8 weeks before pneumococcal vaccine if pursuing the Udani-trial protocol
Other prebiotic intake — total fermentable fiber across all sources adds up

Bottom line: 4.5 g/day mixed into water for at least 4 weeks for prebiotic effect; 8–12 weeks for cold-season or vaccine-adjunct use. Start at 1–2 g/day if you're fiber-sensitive.

3 commercial forms

Compare the main delivery options and what they’re best suited for.

Larch arabinogalactan (Lonza ResistAid)

Most studied

Branded high-purity (≥98%) larch arabinogalactan from western larch (Larix occidentalis), produced by aqueous extraction. The form used in the Udani 2010 and Riede 2013 RCTs and the Lonza GRAS submission. Often the back-of-label '90% arabinogalactan' if a third-party label mentions Lonza.

Not absorbed intact; fermented in colon to short-chain fatty acids.

Larch arabinogalactan (Lonza FiberAid)

Food-grade fiber

Same molecule and source as ResistAid, marketed as a food-fortification fiber rather than a supplement. Used in functional beverages, bars, and meal replacements.

Identical to ResistAid; different product positioning.

Generic larch arabinogalactan powder

Bulk option

Various manufacturers sell bulk powder. Quality and purity vary; look for third-party COA confirming arabinogalactan content and absence of heavy-metal / microbial contamination.

Same prebiotic mechanism if purity is comparable.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

gasbloatingloose stoolsabdominal discomfort at higher doses

Serious risks

  • Larch tree allergies are rare but theoretically possible; cross-reactivity with other tree pollens is not well-characterized.

Who should avoid it

  • People with severe IBS during the elimination phase of a low-FODMAP diet — arabinogalactan is fermentable and can trigger symptoms.
  • People with severe gas / bloating disorders or small intestinal bacterial overgrowth (SIBO) — fermentable fiber may worsen symptoms.
  • People with known larch tree allergy.

Pregnancy & breastfeeding

Larch arabinogalactan is GRAS for general use including in foods consumed by pregnant women. No specific RCT data in pregnancy or lactation. At normal supplement doses (≤4.5 g/day) it is considered safe; discuss with your obstetrician before adding any supplement during pregnancy.

SourceFDA GRAS Notice 119, 2003 — FDA — Larch Arabinogalactan

Bottom line: Well tolerated by most people at studied doses (≤4.5 g/day). Primary side effect is mild GI gas/bloating that usually resolves with continued use or split dosing.

Interactions

no significant drug interactions documentedMinor

Arabinogalactan is not absorbed intact (fermented in colon) and does not interact pharmacokinetically with major drug classes.

SourceFDA GRAS Notice 119, 2003 — FDA — Larch Arabinogalactan
oral medications (any class) taken at the same timeMinor

Like any soluble fiber, may slow absorption of co-administered oral drugs. Separate by 1–2 hours when timing matters.

immunosuppressants (transplant medications, biologics)Minor

Immune-supportive prebiotics theoretically could oppose immunosuppression. Clinical relevance unknown. Discuss with transplant team before adding immune-modulating supplements.

Food sources

Western larch wood (Larix occidentalis) — commercial source

Amount
Not a food; extracted polysaccharide
%DV
—

Carrot, raw or cooked

Amount
1 cup (~150 g) — contains arabinogalactan-protein complexes in cell walls
%DV
—

Pear, apple, tomato

Amount
Trace arabinogalactan in plant cell-wall polysaccharides
%DV
—

Radish, red cabbage

Amount
Trace arabinogalactan in plant cell-wall polysaccharides
%DV
—

Many medicinal herbs (echinacea, baptisia, leptotaenia) — small amounts

Amount
Trace; therapeutically not the main bioactive class
%DV
—

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

Single-ingredient larch arabinogalactan (Lonza ResistAid or FiberAid are the most-studied forms)
Grams of arabinogalactan per serving listed clearly (target 4.5 g/day for studied immune dose)
Tasteless, dissolves cleanly in cold water — that's a positive QC signal
Third-party tested for heavy metals and microbial contaminants
Avoid combination 'immune support' blends that hide the dose of any single ingredient

Be skeptical of…

'Boosts immunity' marketing without acknowledgment of small trial base
'Prevents cold and flu' — modest cold-incidence trend in one trial; not a confirmed prevention claim
Substitute for vaccination — never
Mega-dose products (>10 g/day) — no extra benefit shown, more gas/bloating
Combo 'mushroom + arabinogalactan + zinc + elderberry' formulas where individual ingredient doses are below the studied effective level

Frequently asked questions

Is arabinogalactan a fiber?⌄

Yes, a soluble prebiotic fiber from larch heartwood.

Will it cause gas?⌄

Some bloating possible, especially when starting. Increase gradually.

References by claim

Safety

FDA GRAS Notice 119, 2003 — FDA — Larch Arabinogalactan (2003) link

Prebiotic / gut microbiota support

Kelly, 1999 — Alternative Medicine Review (1999) link

Dion et al., 2016 — Journal of Nutritional Science (2016) link

NIH ODS — Dietary Fiber overview — Office of Dietary Supplements (2024) link

Vaccine antibody response (pneumococcal)

Udani et al., 2010 — Nutrition Journal (2010) link

Common cold incidence reduction

Riede et al., 2013 — Current Medical Research and Opinion (2013) link

Other references

Arabinogalactan on Wikidata — Wikidata link

Track Arabinogalactan with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 31, 2026·Evidence current as of May 31, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.